Made EasySuprasorb X+PHMB Made Easy - Products for Practice

Suprasorb X+PHMB Made Easy - Products for Practice

Complex wounds, Infection | Kingsley A, Kiernan M

Summary
Suprasorb X+PHMB combines a broad spectrum of antimicromicrobial activity and low cytotoxicity with an ability to absorb and release moisture to maintain an optimum moist wound healing environment. This has been shown to reduce wound pain during treatment and provides an alternative option to silver or honey when treating patients with an infected wound or patients who are at risk of infection.

AUTHOR DETAILS
Andrew Kingsley[1], Martin Kiernan[2]

  1. Clinical Manager, Infection Control and Tissue Viability, North Devon District Healthcare NHS Trust
  2. Nurse Consultant, Prevention and Control of Infection, Southport and Ormskirk Hospital NHS Trust


References

  • Alvarez OM, Patel MM, Booker J, Markowitz L (2004) Effectiveness of a biocellulose wound dressing for the treatment of chronic venous leg ulcers: results of a single-centre randomized study involving 24 patients. Wounds 16(7):224-33
  • Best Practice Statement (2011) The use of topical antiseptic/antimicrobial agents in wound management. 2nd edition. Wounds UK, London.
  • Cazzaniga A, Serralta V, Davis S et al (2000) The effect of antimicrobial gauze dressing impregnated with 0.2% polyhexamethylene biguanide (PHMB) as a barrier to prevent Pseudomonas aeruginosa wound invasion. Wounds 14:169-76
  • Denyer J (2009) Management of the infant with epidermolysis bullosa. Infant 5(6):168-71
  • Dissemond J, Gerber V, Kramer A, et al (2010) A practice-orientated recommendation for treatment of critically colonized and locally infected wounds using polihexanide. J Tissue Viability 19(3):106-15
  • Dissemond J, Assadian O, Gerber V, et al (2011) Classification of wounds at risk and their antimicrobial treatment with polihexanide: A practice-oriented expert recommendation. Skin Pharmacology Physiology 24:245-55
  • Eberlein T, Wild T (2008) Approaches to therapy and an outlook on improving the clinical data situation, with a special focus on the polihexanide-containing Suprasorb X+PHMB Hydrobalanced dressing. EWMA conference extended abstract. Available at: http://www.lohmann-rauscher.com/files/1c35745a596ebd89bcd8e12205aca04a/1018/Summary_ICW_-_DGfW_-_EWMA_English.pdf#page=27 [accessed Oct 2011]
  • Elzinga G, van Doorn J, Wiersema AM,  et al (2011) Clinical evaluation of a PHMB-impregnated biocellulose dressing on paediatric lacerations. J Wound Care 20(6):280-6
  • EWMA Position Document (2005) Identifying criteria for wound infection. MEP Ltd, London
  • EWMA Position Document (2004) Wound bed preparation in practice. MEP Ltd, London
  • Fumarola S, Butcher M, Cooper P et al (2010) A clinical audit of Suprasorb® X+PHMB. Wounds UK 6(3):78-87
  • Galitz C, Hammerle G, Signer M (2009) Polihexanide versus silver wound dressings: first interim results of a controlled, randomized, prospective multicenter study. Poster. European Wound Management Association (EWMA) Helsinki/FIN, 20-22 May 2009. EWMA J Supplement 9(3):178-86
  • Gilbert P (2006) Avoiding the resistance pitfall in infection control - does the use of antiseptic products contribute to the spread of antibiotic resistance? Ostomy Wound Manage 52: 10A(suppl);1S-3S
  • Gilliver S (2009) PHMB: a well-tolerated antiseptic with no reported toxic effect. J Wound Care. Activa Healthcare Supplement
  • Glover D, Wicks G (2009) Suprasorb X+PHMB: the clinical evidence. J Wound Care. Activa Supplement
  • Gray D and Cooper P. Effective management of wound infection and quality of life with Suprasorb® X+PHMB. Wounds UK, London 2011.
  • Gray D, Barrett S, Battacharyya M et al (2010) PHMB and its potential contribution to wound management. Wounds UK 6(2): 40-6
  • Hubner NO, Kramer A (2010) Review on the efficacy, safety and clinical applications of polihexanide, a modern wound antiseptic. Skin Pharmacol Physiol 23(suppl 1):17-27
  • Kingsley A, Tadej M, Colbourn A, et al (2009) Suprasorb X+PHMB: antimicrobial and HydroBalance action in a new wound dressing. Wounds UK 5(1):72-7
  • Lee WR, Tobias KM, Bernis DA, Rohrback BW (2004) In vitro efficacy of a polyhexamethylene biguanide-impregnated gauze dressing against bacteria found in veterinary patients. Vet Surg 33(4):404-11
  • Lenselink E, Andriessen A (2011) Clinical effectiveness of polihexanide on biofilms in wounds. Poster presentation at AIUC, Ancona, Italy
  • Moore K, Gray D (2007) Using PHMB antimicrobial to prevent wound infection. Wounds UK 3(2):96-102
  • Mosti G, Mattaliano V, Schmitz M, Abel M (2008) Successful therapy of critically colonized or locally infected wounds with a new HydroBalance biocellulose-based wound dressing with polihexanide on outpatients. Poster presentation. Wounds UK, Harrogate
  • Mudge E, Orsted H (2010). Wound infection and pain management made easy. Wounds International 1(3). Available at: www.woundsinternational.com [accessed Oct 2011]
  • Shah C, Hanson P, Swaniker BS et al (2009) Efficacy and mode of action of a new PHMB impregnated polyurethane foam dressing. Data on file. Available at http://www.forumenfermagem.org/newsletter/images/H6409_Kendall_AMD_Foam_MOA_WP_F.pdf [accessed Oct 2011]
  • Seipp HM, Korber A (2008) Biofilm, fibrin, resistance: antibacterial measures with a focus upon polihexanide. In: Polihexanice - an antimicrobial substance with various properties - for critical colonised or local infected wounds. Lohmann & Rauscher, Neuwield, Germany
  • Werthern M, Davoudi M, Sonesson A e al (2004) Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer. J Antimicrob Chemother 54(4):772-9
  • Wild T, Buckner M, Payrich M, et al (2009) Prospective, randomized study for eradication of MRSA with polihexanide containing biocellulose dressing compared with polihexanide wound solution. Poster presentation, EWMA, Helsinki